Table 1.
Baseline characteristics in 18,673 type 2 diabetic patients aged 30–70 years
| All patients | |
|---|---|
| Lipid measures | |
| Total cholesterol (mmol/L) | 5.06 ± 0.99/5.0 (4.4–5.7) |
| Non-HDL cholesterol (mmol/L) | 3.75 ± 0.98/3.7 (3.1–4.4) |
| LDL cholesterol (mmol/L) | 2.99 ± 0.90/2.9 (2.4–3.5) |
| HDL cholesterol (mmol/L) | 1.31 ± 0.41/1.2 (1.0–1.5) |
| Triacylglycerol (mmol/L) | 1.70 ± 0.77/1.6 (1.1–2.2) |
| TC:HDL | 4.16 ± 1.26/4.0 (3.3–4.9) |
| Non-HDL:HDL | 3.16 ± 1.26/3.0 (2.3–3.9) |
| LDL:HDL | 2.49 ± 1.01/2.4 (1.8–3.1) |
| TG:HDL | 1.48 ± 0.92/1.3 (0.8–2.0) |
| Clinical features | |
| Age (years) | 60 ± 8 |
| Diabetes duration (years) | 7 ± 6 |
| HbA1c (%) | 7.3 ± 1.2 |
| Systolic blood pressure (mmHg) | 140 ± 17 |
| BMI (kg/m2) | 29.6 ± 5.2 |
| Male sex | 60.4 |
| Smoking | 18.9 |
| Albuminuria >20 µg/min | 19.8 |
| History of cardiovascular disease | 13.2 |
| Treatment | |
| Lipid-lowering drugs | 42.0 |
| Hypoglycemic treatment | |
| Diet only | 22.9 |
| Oral agents only | 38.4 |
| Oral agents and insulin | 17.7 |
| Insulin only | 21.0 |
Data are means ± SD/median (25th–75th percentile), means ± SD, or %. SI conversion factor: to convert blood lipids from millimoles per liter to milligrams per deciliter, divide by 0.026 and by 0.011 for triacylglycerol.